Skip to main content
. 2020 Jul 15:nuaa063. doi: 10.1093/nutrit/nuaa063

Table 2.

Vitamin and mineral adjunctive therapies in viral, bacterial, and oncologic diseases

Disease Study design Study year Therapy Findings Reference
Glioma/glioblastoma Phase 2 interventional (clinical trial) 2023 Radiation, temozolomide, vitamin C Ongoing; ending in 2023 Clinical trial NCT0234435537
COVID-19 Randomized, open-label phase 4 trial 2020 Hydroxychloroquine, azithromycin, zinc sulfate, doxycycline Ongoing; ending in 2020 Clinical trial NCT0437078238
Leukemia Phase 2 clinical trial 2020 Azacitidine, vitamin C Ongoing; ending in 2020 Clinical trial NCT0339717339
Sepsis 2019 Vitamin D, standard antibiotic therapy Vitamin D supplementation improved sepsis score and decreased levels of high-sensitivity C-reactive protein Hagag et al (2019)40
Severe pneumonia Retrospective cohort study 2018 Vitamin C, hydrocortisone, thiamine Compared with control group, adjunctive therapy group had lower hospital mortality and higher rate of recovery from severe pneumonia Kim et al (2018)41
Atopic dermatitis Randomized, double-blind, placebo-controlled clinical trial 2018 Vitamin D3 (5000 IU/d), baseline therapy (topical steroid, soap substitute, and emollient) Treatment group had reduced atopic dermatitis severity score Sánchez-Armendáriz et al (2018)42
Hepatitis C Controlled randomized clinical trial 2017 Vitamin C (orange juice), pegylated interferon combined with ribavirin Levels of liver enzyme aspartate aminotransferase decreased in patients who had high levels before the study Gonçalves et al (2017)43
Ehrlich ascites carcinoma Rodent study 2017 Selenium, cyclophosphamide Selenium improved chemotherapeutic effect of cyclophosphamide Bhattacharjee et al (2017)44
Sensorineural hearing loss Nonblinded, noncontrolled study 2015 Vitamin A (26 000 IU), vitamin C (200 mg), vitamin E (200 IU), selenium (50 μg), methylprednisolone (1 mg/kg), trimetazidine dihydrochloride (20 mg, 3 times daily) Treatment with vitamins A, C, and E and selenium was effective in restoring function after sudden idiopathic sensorineural hearing loss Kaya et al (2015)45